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ABSTRACT
Objective: To elaborate a clinical evaluation sheet (CES) of the lower limbs (LL) for diabetic foot (DF) prevention. 
Methods: Based on literature review, a four-phased CES has been elaborated: phases 1 and 2 contemplate 
clinical evaluation (anamnesis and physical evaluation, respectively) with emphasis on feet evaluation and 
search for soreness risk factors; phase 3 evaluates feet care and phase 4 describes the main guidelines for this 
care. Results: With the completion of phases 1 and 2, a feet soreness risk rating follows. Phase 3 evaluates feet 
care with ten questions and phase 4 presents ten educational guidelines for DF prevention. Conclusion: The 
proposed CES enables the detection and early intervention on foot soreness risk. 
Descriptors: Diabetic Foot, Diabetic Neuropathy, Peripheral Vascular Disease, Prevention, Feet Care.
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RESUMO
Objetivo:  Elaborar ficha de avaliação clínica (FAC) dos membros 
inferiores (MIs) para prevenção do pé diabético (PD). Métodos: Partindo 
de revisão da literatura, elaborou-se uma FAC com 4 fases: as fases 1 e 2 
contemplam o exame clínico (anamnese e exame físico, respectivamente) 
com ênfase na avaliação dos pés e na pesquisa de fatores de risco para 
úlceras; a fase 3  avalia o autocuidado com os pés e a  fase 4 descreve as 
principais orientações para este cuidado. Resultados: Após a realização 
das fases 1 e 2, segue uma classificação de risco de ulceração dos pés. A 
fase 3 avalia com dez questões os cuidados com os pés e a  fase 4 apresenta 
dez orientações educacionais para prevenção do PD. Conclusão: A FAC 
proposta possibilita detectar e intervir precocemente no risco de ulceração 
nos pés. 
Descritores: Pé Diabético; Neuropatia Diabética; Doença Vascular 
Periférica; Prevenção; Cuidado Com os Pés.
RESUMEN
Objetivo: Desarrollar formulario de evaluación clínica (FEC) de los 
miembros inferiores (MIs) para la prevención del pie diabético (PD). 
Métodos: A partir de la revisión de la literatura, fue preparada una 
FEC con 4 fases: fases 1 y 2 incluyen examen clínico (anamnesis y la 
exploración física, respectivamente), con énfasis en la evaluación de los 
pies y los factores de riesgo para buscar úlceras; fase 3 se evalúa el auto-
cuidado con sus pies y la fase 4 se describen las pautas principales para 
este tipo de atención. Resultados: Después de la terminación de las fases 
1 y 2 sigue la clasificación de riesgo de la ulceración de los pies. Fase 3 
evalúa con diez preguntas del cuidado de los pies y la fase 4 presenta diez 
directrices educativas para prevenir el PD. Conclusión: La propuesta FEC 
permite detectar e intervenir temprano en riesgo de ulceración de los pies. 
Descriptores: El Pie Diabético; La Neuropatía Diabética; Enfermedad 
Vascular Periférica; Prevención; Cuidado de Los Pies.
INTRODUCTION
Diabetes Mellitus (DM) is one of the main public health 
problems in Brazil and the world, and its prevalence has 
been increasing due to the increase in life expectancy. In 
developing countries, unlike European countries and the 
United States, It is estimated that such increase occurs in all 
age groups and not only in the more advanced ones. Thus, 
it is evident the need to implement public health policies to 
improve the quality of life of individuals affected and their 
families, since this pathology is considered a Primary Care 
Condition, where the appropriate approach by Primary 
Care allows avoiding hospitalizations and deaths due to 
their complications.1 In addition, DM is among the leading 
causes of global morbidity and mortality, being considered 
an epidemic worldwide nowadays.2 
DM is a group of chronic noncommunicable diseases and 
is associated, in the long term, with micro and macrovascular 
complications, which compromise the productivity, 
quality and life expectancy of this clientele.3 Diabetic 
microangiopathy causes diabetic retinopathy, nephropathy 
and neuropathy while macroangiopathy is responsible for 
the onset of cardiovascular diseases, including peripheral 
obstructive arterial disease (PAOD). Cardiovascular disease 
is the main cause of mortality in diabetes mellitus.4-5 
Diabetic foot is a name widely used in medical 
practice to refer to changes in feet resulting from chronic 
complications of diabetes and other associated changes.6 
The diabetic foot (structure of the ankle or below) usually 
presents with infection, ulceration and/or destruction of 
deep tissue associated with neurological abnormalities and 
various degrees of peripheral vascular disease in the lower 
limb. It has a multifactorial etiology and its triggering factors 
include sensorimotor and autonomic neuropathy, PAOD 
and infection.6-8 
Diabetic neuropathy (DN), predominantly characterized 
by sensitivity impairment, constitutes the major risk factor for 
the appearance of foot ulcers that can lead to amputation.9-10 
It manifests after about 15 years of the diagnosis of DM, and 
its prevalence reaches 40%.11 Sensory-motor and autonomic 
neuropathy, PAOD, limitation of joint movement with 
abnormal distribution of the mechanical forces of the feet 
and trophic disorders of the skin are factors implicated in the 
etiopathogenesis of ulcers.12 
The most frequent cause of hospital admissions among 
diabetic patients is related to foot ulcers, whose estimated 
prevalence is 1.4% to 11.9%. Foot ulcers affect about 15% of 
patients with diabetes throughout their lives in Brazil.8 It is 
estimated that the frequency of amputation in diabetic people 
is 10 to 30 times higher than in the general population.13
The diabetic foot can lead to non-traumatic amputations, 
which represent one of the most devastating problems 
associated with the disease, causing great impact in personal 
life, in the family and socioeconomic level, with commitment 
of the individual’s self-image and loss of productive capacity, 
which demonstrates unequivocally the importance of the 
implantation of preventive measures of the diabetic foot in 
the DM.6-7,14
In developed countries amputation results more 
frequently from the association between PAOD and ND, 
whereas in developing countries infection is still the 
most common complication of ulcers that will result in 
amputation.8 About 10% to 25% of diabetics over 70 years 
old will have lesions on the lower limbs, of which 14% to 24% 
will suffer amputation.9 
There is some evidence that diabetic foot complications 
can be prevented.15 Therefore, it is necessary to control blood 
pressure levels, serum lipid and glucose levels, stimulate 
physical activity and weight control, as well as guidelines 
on the importance of smoking cessation and alcoholism.6 
The information, awareness and education of the patient 
for self-care, to ensure adherence to diabetes treatment, as 
well as close collaboration between health professionals and 
patients, are essential elements to avoid the development of 
these complications in order to identify real and potential 
foot problems.3,16
It is reported that an approach that includes close 
monitoring of the patient among other measures can reduce 
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the amputation rates in 49% to 85%.10 This article aims to 
propose a clinical evaluation form (CEF) of the lower limbs 
(LLs) for the prevention of diabetic foot (DF) (Figure 1), as 
a facilitating tool for application by health professionals or 
students in this area duly trained in services that are intended 
to care for the individual with DM. It was developed with the 
purpose of guiding the identification and classification of the 
patient at risk, evaluating and guiding the education of the 
patient and his family for self-care with the feet. 
METHODS
This work resulted from a review of the literature on 
the Virtual Health Library (VHL), periodicals indexed in 
the electronic databases MEDLINE and LILACS, as well as 
textbooks related to the subject, published in Portuguese 
and/or English, covering the period from 1999 to 2015. As 
descriptors were used: “Pé Diabético” (“Diabetic Foot”), 
“Fatores De Risco” (“Risk Factors”), “Neuropatia Diabética” 
(“Diabetic Neuropathy”), “Doença Vascular Periférica” 
(“Peripheral Vascular Disease”), “Prevenção & Controle” 
(“Prevention & Control”) E “Autocuidado Com Os Pés” 
(“Foot Self-care”). 
The inclusion criteria of the articles consisted of studies 
related to the risk factors for diabetic foot and the clinical 
evaluation of diabetic patients, which addressed the methods 
of evaluation of neuropathy and peripheral vascular disease, 
especially those that aimed to identify and classify the foot in 
risk of people with DM.
After reviewing the literature, a preliminary study of the 
material was carried out, from which the texts that served 
as basis for the elaboration of a proposal for an CES were 
selected, aiming at the development of the systematization 
of care by the health professional to the patient with DM , in 
order to prevent the appearance of ulcers and other changes 
that make up the diabetic foot.
The CES uses the interview technique to complete a 
semi-structured questionnaire (phases 1 and 3), records 
general and specific physical examination data (phase 2) and, 
in the end, systematically describes the main educational 
guidelines to prevent DF (phase 4).
This fact sheet is based on: (A) identifying risk factors for 
foot ulceration through anamnesis and physical examination 
and, based on the results obtained, classifying the patient 
as to the risk of such complication (phases 1 and 2); (B) 
assessing adherence to preventive measures of DF, ie whether 
knowledge about preventive foot care is being applied (phase 
3) and; (C) presenting the main educational guidelines that 
should be followed by patients for prevention of DF (phase 4). 
RESULTS
Phase 1 – Anamnesis
This initial part of the clinical file seeks, through a semi-
structured questionnaire, to identify risk factors cited in 
the literature as being associated directly or indirectly with 
the development of foot ulcers. To do so, the elements of 
the anamnesis considered were patient identification and 
risk factors for the development of foot ulcers, personal 
and family history of DM and associated diseases, and an 
investigation of clinical symptoms directed to the presence 
of diabetic neuropathy (DN) and peripheral obstructive 
arterial disease (PAD) in the lower limbs (legs and feet).
Phase 2 - Clinical examination and risk 
classification of diabetic foot
Phase 2 includes general and specific evaluations 
(ectoscopic, physical and instrumental evaluations of the 
vascular and peripheral nerves of the lower limbs) for 
clinical examination. The general evaluations include an 
anthropometric evaluation (weight, height, body mass 
index); blood pressure measurement, dermatological 
evaluation of the feet (skin and faneros) and osteoarticular 
evaluation. Specific evaluations (vascular and neurological) 
will then be performed.
Vascular evaluation proposes the palpation of peripheral 
tibial and posterior pedal pulses and ankle-brachial index 
(ABI) measurements performed in both limbs, and the 
results should be indicated in predetermined fields. The 
neurological assessment of the feet will be based on the 
evaluation of the pain sensations, superficial and thermal 
tactile sensations, as well as evaluation of the foot mobility 
where the interosseous muscles, the gait and the Aquileu 
reflex will be evaluated.
The pressure sensation will also be evaluated with the 
10g monofilament (Semmes-Weinstein monofilament test) 
and the vibration sensitivity with the 128 Hz tuning fork. 
Based on the results obtained, the risk of foot ulceration 
will be assessed and the metabolic control by the glycated 
hemoglobin levels of the last three exams.
Phase 3 - Assessment of self-care with feet
Phase 3 lists a series of 10 questions that assess the patient’s 
self-care at his or her feet. It addresses foot inspection, the use 
of appropriate socks and shoes, hygiene and hydration of the 
feet, nail care and the prevention of injury. This evaluation 
should be repeated at each visit to measure how much the 
diabetic patient is applying these preventive measures in 
their daily routine.
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Phase 4 - Patient guidelines for foot care
At this stage, the main guidelines to be followed by 
patients to prevent diabetic foot are detailed. These guidelines 
consist of simple actions often performed by patients. They 
are mentioned below in a didactic way, in topics and include 
some signs and symptoms of alertness so that the patient 
immediately seeks professionals from the health team for the 
adoption of appropriate actions in the case in question.
1. Daily foot inspection: the feet (plant and back) 
should be inspected DAILY, looking for small 
wounds, blisters or calluses, red spots, nail changes, 
finger injuries, bony prominences, and changes 
in shape, color and temperature of the feet. The 
inspection must necessarily include the sole of the 
feet and it will often be necessary to use a mirror 
or, in the case of visual impairment, it must be 
performed by family members or third parties.10,17-18
2. Wash your feet every day: use warm water (never 
hot) and mild soap and do not leave your feet 
soaking. Dry them thoroughly with a soft dry towel, 
without rubbing the skin, thoroughly wiping the 
skin between the fingers.10,17-18 
3. Hydration of the feet: use oils or moisturizing creams 
to prevent the skin from becoming dry, taking care 
not to apply them between the toes or in areas where 
there are open wounds or cracks. Never use talcum 
powder in the feet, as it causes dryness and thus 
predisposes the appearance of lesions.10,17-18 
4. Always wear clean socks: even in the home. Wear 
clean socks (change daily), comfortable, without 
seams, and preferably cotton, lighter color or 
white, as it facilitates the identification of possible 
injuries.10,17 
5. Shoes: should not have internal seams, should be 
deep enough so that an appropriate removable 
insole can be accomodated, preferably with internal 
padding and adjustable closure (velcro or shoelace). 
Square-tipped footwear is recommended for a 
better fit of the toes and heels will be no more than 
3 cm. They should fully cover the toes and heel 
and be made preferably of soft leather or canvas. 
These specifications allow a reduction of areas of 
plantar pressure and friction, and facilitate the 
accommodation of deformities, if present. Do not 
wear shoes without socks. In the summer, slippers 
may be worn as long, as they do not have a strap 
between the toes, that are hardy and soft and will be 
used early in the morning on leaving the bed.10,17-18 
6. New shoes: should be used gradually. Use them in 
the first few days only at home for a maximum of 
two hours.19 
7. Never walk barefoot: Shoes should always be shaken 
and palpated before use to prevent objects inside 
the shoes from injuring feet, which often have a 
sensitivity change.10,17 
8. Nail cutting: should always be cut straight and not 
too close, preferably after bath (when they are soft), 
with rounded tip scissors in a well-lit environment. 
The straight cut is indicated due to the less possibility 
of injury in the corners of the fingers. Do not try 
to cut nail ingrown, in this situation a specialist 
should be consulted. In cases where there is a vision 
problem you should ask for help of another person 
to cut the nails.10,17-18,20 
9. Callosities: Do not remove the callosities by 
applying any type of chemical agent or plaster. Seek 
professional treatment.10,18 
10. Immediately contact your health care professional: 
in the event of open wounds, blisters, pain in the legs 
when walking or cold and numb legs with pale or 
blue coloring, or lesions in the regions between the 
toes and/or soles of the feet suggestive of “Athlete’s 
foot” (represented by redness, fissures, peeling, 
blisters and usually accompanied by itching).17 
DISCUSSION
The purpose of this article was to elaborate a clinical 
assessment sheet for LLs for diabetic patients, seeking 
objectivity and efficiency in evaluations to identify and 
classify patients at risk of foot ulceration, as well as to 
include in this instrument relevant educational guidelines 
for care with the feet ensuring that these are passed on 
to the patient and his family. The complete file must be 
completed annually; however, phases 3 and 4, regarding 
foot care, should be applied at each visit, until certainty of 
its incorporation into daily practice and from that moment 
the evaluation will be periodic until, in at least once a year at 
the time of the full evaluation.
The prevention of lower limb amputation in diabetics is 
based on the identification and classification of the risk of 
ulceration, early treatment and the adoption of educational 
measures.6 The proposed FAC, supported in the literature, 
is directed to health professionals who take care of diabetics 
to apply in their clinical practice, in their different places of 
action. Its phased structure allows a better organization of 
information and data collected facilitating clinical follow-up.
One of the first concerns in the evaluation of diabetic 
feet is the identification of risk factors for ulceration, which 
is contemplated in the initial part of the proposed file (phase 
1), since, as mentioned in the literature, many risk factors 
for ulceration/amputation can be discovered by means of 
anamnesis, asking themselves about risk factors for diabetic 
neuropathy and atherosclerosis (which is largely responsible 
for peripheral obstructive arterial disease), while others will 
be revealed by the clinical signs and symptoms presented 
at the clinical examination of LLs, in particular, by careful 
clinical examination of the patient’s feet, since various skin 
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changes, callosities, decreased sensitivity among others may 
not be perceived by patients.
Thus, in phase 1, we intend to identify risk factors that 
may influence the development of diabetic foot, such as: 
advanced age (over 60 years); low education level; low 
socioeconomic status, living alone, type 2 diabetes mellitus; 
long duration of the disease (more than 10 years of DM 
diagnosis); personal and family history of other chronic 
complications of diabetes, and other associated diseases 
(obesity, dyslipidemia, depression), unhealthy lifestyles 
(smoking, alcoholism and physical inactivity), inadequate 
glycemic control, among others.20-22    
The risk factor “inadequate glycemic control” in this 
article will be evaluated by means of 3 consecutive doses of 
glycated hemoglobin (Hb A1 C> 7.0%), since this test reflects 
blood glucose levels in the last 120 days long-term glycemic 
control). It is widely established that good metabolic 
control is essential in the prevention of macrovascular and 
microvascular complications of DM, which in diabetic foot 
genesis are represented respectively by peripheral obstructive 
arterial disease and diabetic neuropathy.3
In the anamnesis directed at LLs, symptoms of distal 
sensory neuropathy and vascular insufficiency implicated in 
the development of the “diabetic foot” will be investigated. 
Symptoms related to distal symmetrical polyneuropathy, 
considered to be positive sensory symptoms are: paresthesias 
(stinging, needles), burning of the feet, pain in legs or feet 
that worsen at night, sensory changes in “boot” feet or 
socks, lower members. Neurological symptoms can also be 
negative, and will be searched for, such as numbness in the 
legs or feet, as well as feeling of “dead” feet, evidencing a loss 
of sensitivity. As for the symptoms that show the existence of 
a vascular insufficiency due to PAOD are pain at rest in the 
legs or feet, sensation of cold feet, tiredness (weakness) in the 
legs, intermittent claudication and the presence or history of 
ulcer (open wound) or amputation on the feet.6,23-25 
Intermittent claudication is the symptom most 
commonly associated with PAOD where atherosclerotic 
occlusion of the LLs occurs, causing, due to the resulting 
ischemia, a picture of reproducible pain in the calves, thighs 
or buttocks, which is typically triggered by the act of walking, 
with relief by rest.23 
In phase 2, the risk factors for foot ulceration that directly 
influence diabetic neuropathy such as obesity, identified by 
body mass index (BMI) and systemic arterial hypertension 
will be investigated in the general physical examination. It is 
reported that the risk of developing diabetic neuropathy is 
directly proportional to BMI.21 
In the physical examination of the skin and fanners, by 
means of the inspection technique, the integrity of the skin 
should be evaluated and signs of neuropathy such as calluses, 
dryness, cracks and fissures should be examined. Other signs, 
when present, indicate the presence of vascular insufficiency: 
absence of hair growth, dystrophic (atrophied and mycotic) 
nails, cold skin, paleness to limb elevation, and flushing or 
cyanosis (reactive hyperemia) in the limb’s pendent position. 
Areas of erythema should be investigated, as their occurrence 
may indicate tissue damage and imminent ulceration.6,23-24 
The presence of callosities and/or blisters, early 
complications due to limb insensitivity, indicates the need 
for early intervention with the objective of avoiding foot 
ulceration and a potential amputation.26 The evaluation 
of the toes will be made with attention on the presence 
of onychomycosis and interdigital mycosis (common 
in diabetics), since these infections can lead to a loss of 
cutaneous integrity.13 
The evaluation of the skin and fanners in the proposed 
instrument also seeks to identify existing ulcers and to evaluate 
the presence of previous amputations. History of ulcer and/or 
previous amputation place the patient in a high risk group for 
the affected extremity and for the contralateral limb.6 
The last item of the general clinical examination to 
be approached is evaluation of the osteoarticular system, 
which includes the investigation of deformities, changes 
in joint mobility and Charcot Foot (changes related to 
diabetic neuropathy). Common deformities such as the 
claw toe (hyperextension of the metatarsophalangeal joint 
with interphalangeal flexion) or hammer toe (extension of 
the distal phalanx) are associated, due to increased plantar 
pressures, the lesion of this region.24 
In the evaluation of joint mobility, movements of flexion, 
inversion and eversion of the ankle should be tested, as 
well as those of the first metatarsophalangeal joint, which 
are usually the most involved in diabetic neuropathy and, 
when altered, are risk factors for the appearance of plantar 
ulceration in individuals with protective sensitivity.27 
Examination of the joint system will end by evaluating the 
presence of Charcot Foot. In this condition, there is an acute 
and localized inflammatory process that affects the bones, 
joints and soft tissues of the ankle and foot, leading to bone 
destruction, subluxation, displacements and deformities, 
leading to the collapse of the midfoot. In the acute phase 
(acute Charcot), inflammatory, with the classic phlogistic 
signs of heat, tumor, flushing and pain, there may be little 
pain symptomatology due to the marked impairment of 
sensitivity, whereas in the chronic and more advanced phase 
(chronic Charcot) will predominate important osteoarticular 
muscles of the middlefoot, with the appearance of calluses 
and plantar ulcers.6,28 
The presence of neuropathic abnormalities characterized 
by the involvement of fine nerve fibers (types A-delta and C) 
and thick nerve fibers (type A-beta) will also be evaluated 
at this stage. The former function as receptors for painful 
stimuli of thermal, mechanical, or chemical origin, as well as 
receiving the thermal stimuli that are innocuous. The thick 
fibers of the A-beta type are responsible for the perception 
of touch, the deep and vibratory sensitivities and are later 
affected by diabetes in relation to the fine fibers.29 
When there is the involvement of fine fibers there are 
alterations: in the sensitivity to the light touch (superficial) 
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that in the CES will be investigated by the use of a cotton pad 
to be applied in the back of the feet; in the pain sensitivity, 
which will be evaluated by means of a needle (or pin) slightly 
placed in contact with the back of the feet, and finally in the 
thermal sensitivity, evaluated by means of cold and warm 
water, applied in said region. The results will be noted as 
preserved or altered sensitivity and the location of the change 
specified, if present.30 
The inability to feel the needle bite (or pin) applied to 
the dorsal side of the hallux sufficiently to cause a pressure 
deformity, proximal to the nail, is defined as the absence 
of perception in any of the hallux, and is associated with a 
increased risk of foot ulceration.24 
Foot ulcers occur as a consequence of loss of plantar 
protective sensibility and can be defined as the level of 
sensory loss that allows damage to occur in the skin and is 
not perceived as such by the affected individual, who often 
thinks that he has a normal sensitivity level. It is from this 
sensory loss that the infectious complications originate and 
the potential damage that can culminate in limb amputation. 
The primary event for ulceration is neuropathy, not 
arterial disease.31  
In the presence of thick fiber involvement, which occurs 
commonly in diabetic neuropathy, there is loss of plantar 
protective sensitivity and its early detection through the 
use of Semmes-Weinstein monofilament and the 128 Hz 
Tuning Fork Test allows for preventive measures that prevent 
progression to foot ulceration.32
The use of Semmes-Weinstein (SW) monofilaments, 
according to several prospective studies, demonstrates that 
in the absence of pressure sensation with 10g monofilament, 
there is a high prediction for subsequent ulceration.24 The 
technique recommended by the International Working 
Group on Diabetic Foot (IWGDF), adapted by the Brazilian 
Society of Diabetes, will be adopted, which recommends 
testing at 4 points instead of 3. In this test, the monofilament 
will be applied to 4 plantar areas: distal phalanx of the hallux, 
1st, 3rd and 5th metatarsals, which gives the test a sensitivity 
of 90% and specificity of 80%.3 
The monofilament should be applied perpendicular to 
the skin surface with sufficient pressure to arcuate it, thus 
remaining for approximately 2 seconds. There will be 3 
questions (for each region) regarding the patient’s perception 
of touch, whom should answer yes or no. 2 applications will 
be real and 1 will be simulated without the patient being able 
to see what the examiner is doing. The protective plantar 
sensitivity will be considered present for each test region if 
the patient responds correctly 2 of the 3 questions.10 
There are several prospective studies that confirm 
monofilament as the ideal instrument for tracking diabetic 
foot.3 The test results will be noted in a specific field on the 
clinical chart as normal or changed for both lower limbs, and 
marked changes in footprints in the corresponding areas.
The evaluation of the vibration sensitivity through the 
128 Hz tuning fork (where there is a field with normal/
altered options for both lower limbs) will be performed. 
This will be placed in a bony part on the dorsal surface of 
the distal phalanx of both hallux, perpendicularly and with 
a constant pressure, without the patient beeing able see the 
procedure. The contact of the tuning fork with the area 
examined will be repeated, but it must be switched with a 
time when there is only simulation of the tuning fork, and 
the vibration sensitivity will be preserved if at least 2 of 3 
responses are correct. If the test is abnormal, the individual 
will be considered as “at risk of ulceration”.10 It should be 
emphasized that a response is considered abnormal when 
the individual ceases to feel the vibration while the examiner 
is still able to perceive it.13  
At the end of the neurological evaluation of this clinical 
record, the patient’s motor function will be investigated. It 
will be observed the presence or absence of atrophy of the 
intrinsic muscles of the foot, which may contribute to the 
increase of the plantar pressures due to the appearance of 
deformities and decrease of the range of movement of the foot 
and ankle, with evolution to callosities and pressure ulcers.27,33 
Changes in gait result from the reduction of various 
types of ankle and foot movements, compromising the 
ability to absorb shock and transverse rotations during 
walking, contributing to the appearance of plantar ulcers 
in the insensible foot, thus justifying its evaluation in the 
proposed CES.27 
The presence of abnormality of the Aquileu reflex has 
been associated with an increased risk of foot ulceration in 
univariate and multivariate analyzes,34 and will be searched 
by means of a reflex hammer, which will be applied after the 
ankle is placed in a neutral position.24 After evaluation of the 
peripheral nervous system, the peripheral arterial system 
will be appreciated. It is widely recognized that PAOD is a 
risk factor for lower limb amputation in diabetics.35 
Often, the picture resulting from this obstruction is 
more subtle in diabetics when compared to non-diabetic 
individuals, which can be explained by the concomitant 
neuropathic involvement, which causes many individuals 
to be asymptomatic, with about one third developing 
intermittent claudication. Even in asymptomatic individuals, 
the presence of arteriopathy is a marker for systemic vascular 
disease (systemic atherosclerosis), with involvement of the 
cerebral, coronary and renal arteries, which shows the high 
risk level for acute events such as acute myocardial infarction, 
stroke and death, emphasizing that the major cause of death 
and disability, mainly in type 2 diabetics, is atherosclerosis.3,23 
Thus, the palpation of the posterior tibial and pedicular 
pulses is mandatory in the diabetic individual. The peripheral 
arterial obstruction due to atherosclerosis causes a distal 
reduction of blood flow and perfusion pressure. Vascular 
involvement is diffuse and especially severe in the tibial and 
patellofemoral arteries, and the prevalence of long occlusions 
is high.36 
In addition to palpation of the wrists, which may 
sometimes diverge between observers leaving doubts, it is 
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recommended to measure the ankle-brachial index (ABI) 
with a manual Doppler 8-10MHz transducer. Taking into 
account that 50% of diabetic patients have PAOD, and that 
ABI can be easily calculated, besides being an objective and 
reproducible method for the screening of arterial disease, 
its cost is very small when compared to the benefits it 
provides in the diabetic foot with ischemia associated or not 
with neuropathy.3  
ABI, a noninvasive measure for the detection of 
peripheral obstructive arterial disease and its severity, is 
obtained with the use of portable vascular Doppler and 
a sphygmomanometer. The systolic pressure of the distal 
arteries of both lower limbs (posterior tibial and dorsal pedial) 
is affected and the largest value obtained by the highest value 
observed in the measurement of the brachial artery systolic 
pressure is divided. This index will be calculated for each 
lower limb, emphasizing that the denominator is common 
to both lower limbs (greater systolic pressure obtained in the 
brachial arteries) and the numerator will be specific for each 
limb.3,23-24,36 It will be considered without PAOD the ABI> 
0.90, with values ≤ 0.90 suggesting arterial obstruction.23,36 
After performing the osteoarticular evaluations, 
plantar protective sensitivity by 10g monofilament and 
vascular assessment for the presence/absence of peripheral 
obstructive arterial disease, diabetic foot risk classification 
will be performed, where treatments/recommendations 
will be proposed, as well as follow-up time and the need for 
follow-up with generalist and/or specialist.3
Phase 3 of this CES refers to the evaluation of self-care 
with the feet, identifying the level of knowledge of the 
diabetic patient regarding prophylactic measures and the 
degree of adherence to self-care. It is well known that patients 
with DM present failures in the prevention of diabetic foot 
and its complications, with unfavorable repercussions on 
quality of life.16,37 
The prevention of foot injuries (ulcers and amputations) 
of the person with diabetes requires an interaction with the 
team responsible for their care, which is able to sensitize 
the patient and promote a behavior change that favors their 
performance as a co-participant in preventive measures, 
where the health professional should evaluate the knowledge 
acquired and the skills necessary for self-care.16,38 
In this phase of the FAC, if the non-adherence to the self-
care procedures is evidenced, the health professional should 
guide the diabetic, sensitizing him/her to the strategies 
of prevention of foot injuries and, at each subsequent 
consultation, reassess them as to preventive measures.
Phase 4 is intended to instruct and educate DM patients 
to practice self-care with their feet. Such an educational 
process allows to increase the motivations and abilities of the 
patients in the recognition of the actual and potential risks 
and to provide them with the guidelines of the measures 
they should take in such situations, emphasizing that the 
complications related to diabetic foot represent about 40 to 
70% of all lower extremity amputations.10,39  
A prospective study that followed a group of diabetics for 
24 months with the intervention of a podiatrist and a diabetes 
educator showed a significant reduction in the occurrence of 
such complications.18 Another study, which lasted six years, 
showed an effective reduction of ulcers, with a cumulative 
percentage of 3.1% in the group that underwent the 
educational intervention against 31.6% in the control group.18 
Recently, in a study in Denmark, amputation rates among 
diabetics were reduced by 10% considering low amputations 
(below the ankle) and 15% for averages (from ankle to knee) 
when self-care was performed and stimulated.40 
The existence of a channel of direct and immediate 
communication between the health team and the patient 
allows the reporting of recent changes in the feet, which will 
allow us to direct it to a timely diagnosis and an effective 
treatment, through intervention in factors of modifiable risk.17
CONCLUSION
This article aimed at the elaboration of a clinical form 
for prevention of diabetic foot. The proposed CES makes 
it possible to detect the foot at risk of ulceration early, 
to assess the degree of self-care with the feet and to guide 
patients and their families with regard to foot care, and the 
instruments used to assess the foot at risk of low cost and 
simple application by health professionals. Comparing the 
costs generated by the complications that are proposed to 
avoid, the CES presents a low cost and ease of execution 
by multidisciplinary team members who have undergone 
previous training. 
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Figure 1
Clinical evaluation of lower limbs form for prevention of diabetic foot
Phase 1 - Anamnesis
Identification              
Date: ___/___/___
Name: __________________________________________  Registration:______________
Address: _______________________________________________________________
Telephone: _______________   
Date of birth: ____/____/____
Sex: _______________              
Race: a) white (   )             b) brown (   )             c) black (   )             d) other (   )
Marital status: ___________________          Occupation: ______________________________
Scholarity: ___ (years of study)       Family income: ______ (in minimum wages)
History of diseases (personal and family)
Type of diabetes:
Type 1 (   )         Type 2 (   )          Other (   )          Age at diagnosis: _____ years old
Duration of diabetes (in years): _____
Type of DM treatment: Insulin (___) Yes (___) No
Oral drugs: (    ) Yes (    ) No Other: __________________________________
Other associated diseases: (    ) Yes (    ) No    Which: _______________________
Family history:
Risk Factors for Foot Ulcers
Inadequate glycemic control (Hb A1c >7,0% in 3 exams) (   ) Yes    (   ) No
Duration of diabetes (≥10 years) (   ) Yes    (   ) No
Elderly (>60 years old) (   ) Yes    (   ) No
Dyslipidemia (hypercholesterolemia, hypertriglyceridemia and low HDL) (   ) Yes    (   ) No
Arterial hypertension (   ) Yes    (   ) No
Retinopathy (researched with fundoscopy) (   ) Yes    (   ) No
Nephropathy (albuminuria research) (   ) Yes    (   ) No
Obesity (BMI≥30 kg / m2) (   ) Yes    (   ) No
Sedentary lifestyle (   ) Yes    (   ) No
Smoking (   ) Yes    (   ) No
Alcohol consumption (   ) Yes    (   ) No
High stature (   ) Yes    (   ) No
Low visual acuity (   ) Yes    (   ) No
Psychosocial factors (denial of illness, low social status, living alone) (   ) Yes    (   ) No
Inadequate shoes and / or walking barefoot (   ) Yes    (   ) No
1.4 Anamnesis directed to the lower limbs (legs and feet)
PNSD Positive Sensitive Symptoms Member affected
Burning sensation in the feet?
(   ) Yes     (   ) No
R (   )     L (   )
Stinging/pricking sensation in legs or feet?
(   ) Yes     (   ) No
R (   )     L (   )
Pain in legs or feet that get worse at night?
(   ) Yes     (   ) No
R (   )     L (   )
Feel sensitive changes on the feet wearing boots or socks?
(   ) Yes     (   ) No
R (   )     L (   )
Lancinating pain in the lower limbs?
(   ) Yes     (   ) No
R (   )     L (   )
(To be continued)
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Time related to the onset of positive sensory symptoms:
(   ) less than 30 days                   (   ) 30 – 60 days                   (   ) over 60 days
PNSD Negative Sensitive Symptoms Member affected
Numbness in legs or feet?
(   ) Yes     (   ) No
R (   )     L (   )
Feel leg / foot as if it were “dead”?
(   ) Yes     (   ) No
R (   )     L (   )
PAOD Vascular symptoms Member affected
Tiredness (weakness) in the legs?
(   ) Yes     (   ) No
R (   )     L (   )
Feel cold feet?
(   ) Yes     (   ) No
R (   )     L (   )
Resting pain in the legs or feet?
(   ) Yes     (   ) No
R (   )     L (   )
Pain when walking small, medium or large distances that improves with rest (intermit-
tent claudication)?
(   ) Yes     (   ) No
R (   )     L (   )
Ever had an ulcer (open wound) or an amputation in your feet?
(   ) Yes     (   ) No
R (   )     L (   )
Phase 2 - Clinical examination and risk classification of diabetic foot
2.1 Anthropometric and blood pressure data
Weight: _____ Kg                         Height: _____ m2                                BMI _____ Kg/m2
Blood pressure (mmHg): Right arm: ______________ Left arm:___________
2.2 Clinical examination of the lower limbs
2.2.1 Clinical examination of skin and faneros (legs and feet)
Signs of Peripheral Autonomic Neuropathy
Dry and scaly skin
(   ) Yes     (   ) No
R (   )     L (   )
Reddened skin (hyperemia)
(___) Yes (___) No            
R (   )     L (   )
Loss of nails
(___) Yes (___) No
R (   )     L (   )
Callosities
(___) Yes (___) No
R (   )     L (   )
Feet clefts
(___) Yes (___) No
R (   )     L (   )
Abnormality in sweating of feet
(___) Yes (___) No
R (   )     L (   )
Edema
(___) Yes (___) No
R (   )     L (   )
Hot foot
(___) Yes (___) No
R (   )     L (   )
Vascular Ectasias
(___) Yes (___) No
R (   )     L (   )
Signs of DAOP
Cold skin
(___) Yes (___) No
R (   )     L (   )
Thin and shiny skin
(___) Yes (___) No
R (   )     L (   )
(To be continued)
(Continuation)
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Thinning of hair
(___) Yes (___) No
R (   )     L (   )
Dystrophic fingernails
(___) Yes (___) No
R (   )     L (   )
Skin pallor
(___) Yes (___)No
R (   )     L (   )
Color of the limb when lifting it: pallor
(___) Yes (___) No
R (   )     L (   )
Pendent limb color: flushing or cyanosis
(___) Yes (___) No
R (   )     L (   )
Ulcers         (___) Yes (___) No
Amputations  (___) Yes (___) No
R (   )     L (   )
R (   )     L (   )
Signs suggestive of infection/inflammation/trauma
Erythema
(___) Yes (___) No
R (   )     L (   )
Inflammation of the nail fold (Paronychia)
(___) Yes (___) No
R (   )     L (   )
Blisters
(___) Yes (___) No
R (   )     L (   )
Interdigital mycosis
(___) Yes (___) No
R (   )     L (   )
Onicomicosis
(___) Yes (___) No
R (   )     L (   )
2.2.2 Clinical examination of the osteoarticular system
Signs of diabetic neuropathy
Foot deformities:
Claw, hammer, fingers etc.
(___) Yes (___) No
R (   )     L (   )
Which: _____________________________________________________________________         
Abnormal shape of the foot (foot cavus, flat, foot in drop, etc.)
(___) Yes (___) No
R (   )     L (   )
Which: _____________________________________________________________________         
Charcot foot
(___) Yes  (___) No
R (   )     L (   )
Altered foot joint mobility
(___) Yes (___) No
R (   )     L (   )
2.2.3 Record of abnormalities in the clinical examination of the feet
Right Left Indicate by placing the corresponding letters where there is:          
 
C = Calluses
D = Deformities
F = Fissures or cracks
U = Ulceration     
Neurological evaluation
2.2.4.1  Surface Sensitivity Examination
(To be continued)
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Thermal (application of cold/heated water):
R Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
L Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
Painful (needle stick/toothpick on the dorsum of the foot):
R Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
L Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
Tactile (cotton on the dorsum of the foot):
R Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
L Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
2.2.4. 2 Semmes-Weinstein Monofilament Pressure Perception Evaluation
Right Left Indicate the level of sensation in the circles:
  
+ = Can feel the 10g nylon filament
- = Can not feel the 10g nylon filament
Right foot: normal () changed ()
Left foot: normal () changed ()
NOTE: If there is no sensitivity, the foot is at risk of ulceration.
2.2.4.3Evaluation of Vibratory sensitivity (with Tuning Fork of 128 Hz)
Distal phalanx of the right hallux:  (   ) normal    (   ) reduced      (   ) abolished
Distal phalanx of the left hallux:   (   ) normal    (   ) reduced      (   ) abolished
2.2.4.4 Motor Rating
Gear shift
Type:_________________
(___) Yes (___) No
R (   )     L (   )
Atrophy of the leg
(___) Yes (___) No              
R (   )     L (   )
Atrophies of interosseous muscles of the metatarsus
(___) Yes (___) No
R (   )     L (   )
Muscular weakness
(___) Yes  (___) No
R (   )     L (   )
Aquileu Reflection:
R Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
L Foot: (   ) normal (   ) reduced (   ) absent (   ) increased
2.2.5 Evaluation of the vascular system
2.2.5.1. Peripheral pulses
Palpable posterior tibial pulse
(___) Yes
(___) No
R (   )     L (   )
R (   )     L (   )
Palpable pedal pulse
(___) Yes
(___) No
R (   )     L (   )
R (   )     L (   )
2.2.5.2 Diagnostic criteria for PAOD based on the Ankle-Brachial Index (ABI)
ABI:  Without PAOD : > 0,9 (      )   PAOD: ≤ 0,9 (      )
2.3  Diabetic foot risk classification
Risk Definition
Treatment/
Recommendations
Follow-up
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(Continuation)
ISSN 2175-5361. DOI: 10.9789/2175-5361.2017.v9i3.899-913
Mello RFA; Pires MLE; Kede J Clinical evaluation form of...
J. res.: fundam. care. online 2017. jul./sep. 9(3): 899-913 912
0
No PSP*
No PAOD**
No deformities
Education/Proper footwear
Yearly (Generalist or
specialist)
1 PSP+Deformities
Proper footwear prescrip-
tion
Surgery if indicated (pro-
phylactic)
Every 3-6 months
2 PSP+PAOD
Proper footwear prescrip-
tion
Consultation with vascular
Every 2-3 months
(specialist)
3 Ulcer, prior amputation
Like in 1
Follow-up with vascular
Every 1-2 months
(specialist)
*PSP: Loss of Protective Planting Sensitivity;
** POAD: Peripheral Obstructive Artery Disease
Retrieved from SBD- Guidelines 2013-2014 Reference 3
Phase 3 - Assessment of self-care
1- Examines feet daily for blisters, calluses, wounds, redness, or any other change, including on the soles of the feet or bet-
ween the toes?
(___) Yes (___) No                  
2- Washes feet every day with warm water and soap and then dryes feet and between fingers with a soft, dry towel, without 
rubbing the skin?
(___) Yes (___) No
3- Removes cuticles with pliers, cut ingrown nails or calluses?
(___) Yes (___) No          
4- Cuts nails straight with scissors with rounded tips?
(___) Yes (___) No
5- Uses moisturizer on feet daily, but never between the toes?
(___) Yes (___) No
6- Wears clean, comfortable socks, made of wool or cotton and seamless?
(___) Yes (___) No
7- Walks barefoot or wearing slippers with straps between your toes?
(___) Yes (___) No
8- Wears shoes that are tight or uncomfortable for your feet?
(___) Yes (___) No 
9- Examine the shoes and shake them before using them?
(___) Yes  (___) No
10- Pays attention to the places you walk to avoid foot injuries?
(___) Yes (___) No
Phase 4 - Foot Care Guidelines
1. Examine your feet daily for blisters, calluses, wounds, redness, or any other change, including on the soles of the feet or 
between the toes. If necessary use a mirror or ask for help from a relative or other person.
2. Wash your feet every day with warm soapy water and neutral soap. Avoid hot water. Do not leave your feet immersed. 
Dry your feet well with a soft, dry towel, thoroughly wiping the skin between your fingers, especially between the last toes.
3. Hydrate your feet: a moisturizing cream, but not between the toes or in areas where there are open wounds or cracks. Do 
not use talc, as it causes dryness and thus predisposes the appearance of lesions.
4. Wear clean socks: change them daily. They should be comfortable, no seams, and preferably cotton, lighter color or white, 
as it facilitates the identification of possible injuries. Do not wear shoes without socks.
5. Shoes: only shoes that do not tighten and completely cover the toes and heel, made of soft leather or canvas and without 
internal seams. Square-foot shoes are recommended for a more adequate arrangement of the fingers. Heels of up to 3 cm. 
In the summer, slippers can be worn that have no strap between the toes, be resilient and soft and its use will start in the 
morning when you leave the bed.
6. New shoes: should be used gradually. Use them in the first few days only at home for a maximum of two hours.
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7. Never walk barefoot: shoes should always be palpated inside and shaken to remove debris before using them to prevent 
objects inside your foot from injuring your feet.
8. Nail cutting: Always be straight and not too tight, preferably after bathing (when they are soft), with rounded-tipped 
scissors. In case of vision problems ask someone else’s help to cut the nails.
9. Calluses: Do not remove corns, nor try to fix ingrown nails. Seek professional treatment.
10. Call your doctor or health care provider right away if you have calluses, cracks, scaling, blisters, itching, or wounds on 
the feet (including the soles of the feet and regions between the toes) and also in case of leg pain at walking or cold, numb 
legs with paleness or bluish coloring.
References 10, 17, 18, 19, 20
Clinical Impression: 
Foot at risk of ulceration    (___) Yes  R  (___)   L (___)
                                              (___) No   R  (___)    L (___)                                              
___________________________________________
Professional responsible for filling (signature and stamp)
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